ESR1 and neoplasm: These include the production of estrogen receptor-positive and progesterone receptor-positive (ER+PR+) and ER−PR− tumours from mouse basal and luminal cells engineered separately to express PIK3CA(H1047R), thereby creating models that appear to mirror analogous phenotypes of human breast cancer64, 65.